Concepedia

Andria L. Del Tredici

AL

13

Publications

663

Citations

13

H-Index

2003

Active since

Affiliations

Acadia Pharmaceuticals (United States)(Current)

Millennium Engineering and Integration (United States)

University of North Carolina at Chapel Hill

University of Utah

Icahn School of Medicine at Mount Sinai

Andria L. Del Tredici is an author at Acadia Pharmaceuticals (United States) specializing in medicine, pharmacology, and pain medicine.

ORCID

Top concepts

Publications per year

2003–2020

13

Publications

13

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Kimberly E. Vanover, David M. Weiner, Malath Makhay et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 196 citations · Full text

Frequency of CYP2D6 Alleles Including Structural Variants in the United States

Andria L. Del Tredici, Alka Malhotra, Matthew Dedek et al. · Frontiers in Pharmacology · 2018 · 124 citations · Full text

Recommendations for Clinical Warfarin Genotyping Allele Selection

Victoria M. Pratt, Larisa H. Cavallari, Andria L. Del Tredici et al. · Journal of Molecular Diagnostics · 2020 · 65 citations · Full text

, , +5

Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist

Fabrice Piu, Cindy Cheevers, Lene Hyldtoft et al. · European Journal of Pharmacology · 2008 · 40 citations

, , +11

Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes

Andria L. Del Tredici, Carsten Andersen, Erika A. Currier et al. · Molecular Pharmacology · 2007 · 38 citations

Rows per page

1–5 of 13